- Record: found
- Abstract: not found
- Article: not found
Pharmaceutical firms and the construction of drug markets: from branding to scientific marketing
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Most cited references16
- Record: found
- Abstract: not found
- Article: not found
Promoting Agency Reputation through Public Advice: Advisory Committee Use in the FDA
Susan L. Moffitt (2010)
- Record: found
- Abstract: not found
- Article: not found
Introduction: drug trajectories
Jean-Paul Gaudillière (2005)
- Record: found
- Abstract: not found
- Article: not found
The Moral Economy of the Drug Company–Medical Scientist Collaboration in Interwar America
Nicolas Rasmussen (2016)
Author and article information
Comments
Comment on this article
scite_
Similar content2,056
Cited by1
- The symbolic economy of drugsGreeneJeremy, Generic: The Unbranding of Modern Medicine (Baltimore, MD: The Johns Hopkins University Press, 2014), 368 pp., $29.95. ISBN 9781421414935.GabrielJoseph, Medical Monopoly: Intellectual Property Rights and the Origins of the Pharmaceutical Industry (Chicago, IL: The University of Chicago Press, 2014). 328 pp., $35. ISBN 9780226108186.HealyDavid, Pharmageddon (Berkeley, CA: University of California Press, 2012), 320 pp., $41.95. ISBN 9780520270985.PetersonKristin, Speculative Markets: Drug Circuits and Derivative Life in Nigeria (Durham, NC: Duke University Press, 2014), 256 pp., $23.95 (pbk). ISBN 9780822357025.Authors: Antoine Lentacker